EcoPrestMet

EcoPrestMet predicts combination antimicrobial therapies by integrating high-throughput metabolomics with metabolic and chemogenomic profiles to identify drug–drug interactions and inhibited gene functions in Escherichia coli.

Key Features:

• High-Throughput Metabolomics: Integrates high-throughput metabolomic data with metabolic and chemogenomic profiles to analyze drug-induced metabolic responses.
• Large-Scale Drug Screening: Analyzes a dataset comprising 1,279 drugs to assess potential combinatorial interactions.
• Metabolic Profiling and Gene Function Inhibition: Combines metabolic profiling of drug responses with data from 3,807 single-gene deletion strains to map inhibited gene functions.
• Prediction of Drug–Drug Interactions: Predicts drug–drug interactions using combined metabolomic and chemogenomic information.
• Rational Design of Drug Combinations: Uses metabolic and genetic interaction insights to inform selection of synergistic drug combinations.
• Compendium of Drug-Associated Metabolome Profiles: Generates a compendium of drug-associated metabolome profiles for systematic analysis.
• Applicability Beyond Microbiology: Employs principles and data types that are applicable to exploring complex drug interactions in other therapeutic areas.

Scientific Applications:

• Understanding Drug Tolerance and Resistance: Reveals metabolic and genetic mechanisms underlying drug tolerance and antibiotic resistance in Escherichia coli.
• Drug Repurposing: Identifies potential new therapeutic uses for existing drugs based on metabolomic response patterns.
• Design of Combination Therapies: Supports rational selection of combination antimicrobial therapies to improve efficacy and mitigate side effects.
• Cross-disciplinary Interaction Mapping: Enables systematic exploration of complex drug interactions across different fields of medicine.

Methodology:

Integrates high-throughput metabolomic data with metabolic and chemogenomic profiles and analyzes metabolic responses across 1,279 drugs and 3,807 single-gene deletion strains to predict drug–drug interactions and inhibited gene functions in Escherichia coli.